Normative Data for Macular Thickness by High-Definition Spectral-Domain Optical Coherence Tomography (Spectralis)

Purpose To establish normative data for the macular thickness by spectral-domain optical coherence tomography (SD-OCT) in subjects with no known retinal disease. Design Prospective, observational study in an academic institutional setting. Methods Fifty subjects (age range, 20 to 84 years) with no k...

Full description

Saved in:
Bibliographic Details
Published in:American journal of ophthalmology Vol. 148; no. 2; pp. 266 - 271
Main Authors: Grover, Sandeep, Murthy, Ravi K, Brar, Vikram S, Chalam, Kakarla V
Format: Journal Article
Language:English
Published: New York, NY Elsevier Inc 01-08-2009
Elsevier
Elsevier Limited
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Purpose To establish normative data for the macular thickness by spectral-domain optical coherence tomography (SD-OCT) in subjects with no known retinal disease. Design Prospective, observational study in an academic institutional setting. Methods Fifty subjects (age range, 20 to 84 years) with no known retinal disease, best-corrected visual acuity 20/20, and normal intraocular pressure were enrolled. The subjects were divided into 3 age groups: group 1 included subjects 20 to 40 years of age; group 2 included subjects 41 to 60 years of age; and group 3 included subjects 61 years of age and older. All subjects underwent a complete ophthalmologic examination to rule out any retinal diseases or glaucoma. All the OCT scans were performed by a single operator, and data obtained from the right eyes were analyzed by default, unless the right eye did not meet the inclusion criteria, and then data from left eyes were analyzed (n = 4). Central point thickness (CPT) and retinal thickness (RT) in 9 Early Treatment Diabetic Retinopathy Study (ETDRS) subfields, including central subfield (CSF), were analyzed. Statistical analyses were carried out using the analysis of variance. Results Overall, the mean CPT was 227.3 ± 23.2 μm, and mean CSF was 270.2 ± 22.5 μm. Among the ETDRS subfields, the outer nasal quadrant had the maximum thickness (mean ± standard deviation, 339.5 ± 16.9 μm). The RT did not show significant difference with age ( P = .62) or with gender ( P = .1). However, there was a suggestion of significant difference in RT of Black subjects as compared with White subjects ( P = .007) in the present study. Conclusions Normative values for macular thickness in otherwise healthy eyes were measured to be 227.3 μm (CPT) and 270.2 μm (CSF) using commercially available Spectralis SD-OCT. Based on the data, the present study proposes the guidelines for normal CSF thickness to be 315 μm for future studies using macular thickness measurements with Spectralis SD-OCT (Heidelberg Engineering, Vista, California, USA).
AbstractList PURPOSETo establish normative data for the macular thickness by spectral-domain optical coherence tomography (SD-OCT) in subjects with no known retinal disease.DESIGNProspective, observational study in an academic institutional setting.METHODSFifty subjects (age range, 20 to 84 years) with no known retinal disease, best-corrected visual acuity 20/20, and normal intraocular pressure were enrolled. The subjects were divided into 3 age groups: group 1 included subjects 20 to 40 years of age; group 2 included subjects 41 to 60 years of age; and group 3 included subjects 61 years of age and older. All subjects underwent a complete ophthalmologic examination to rule out any retinal diseases or glaucoma. All the OCT scans were performed by a single operator, and data obtained from the right eyes were analyzed by default, unless the right eye did not meet the inclusion criteria, and then data from left eyes were analyzed (n = 4). Central point thickness (CPT) and retinal thickness (RT) in 9 Early Treatment Diabetic Retinopathy Study (ETDRS) subfields, including central subfield (CSF), were analyzed. Statistical analyses were carried out using the analysis of variance.RESULTSOverall, the mean CPT was 227.3 +/- 23.2 microm, and mean CSF was 270.2 +/- 22.5 microm. Among the ETDRS subfields, the outer nasal quadrant had the maximum thickness (mean +/- standard deviation, 339.5 +/- 16.9 microm). The RT did not show significant difference with age (P = .62) or with gender (P = .1). However, there was a suggestion of significant difference in RT of Black subjects as compared with White subjects (P = .007) in the present study.CONCLUSIONSNormative values for macular thickness in otherwise healthy eyes were measured to be 227.3 microm (CPT) and 270.2 microm (CSF) using commercially available Spectralis SD-OCT. Based on the data, the present study proposes the guidelines for normal CSF thickness to be 315 microm for future studies using macular thickness measurements with Spectralis SD-OCT (Heidelberg Engineering, Vista, California, USA).
Purpose To establish normative data for the macular thickness by spectral-domain optical coherence tomography (SD-OCT) in subjects with no known retinal disease. Design Prospective, observational study in an academic institutional setting. Methods Fifty subjects (age range, 20 to 84 years) with no known retinal disease, best-corrected visual acuity 20/20, and normal intraocular pressure were enrolled. The subjects were divided into 3 age groups: group 1 included subjects 20 to 40 years of age; group 2 included subjects 41 to 60 years of age; and group 3 included subjects 61 years of age and older. All subjects underwent a complete ophthalmologic examination to rule out any retinal diseases or glaucoma. All the OCT scans were performed by a single operator, and data obtained from the right eyes were analyzed by default, unless the right eye did not meet the inclusion criteria, and then data from left eyes were analyzed (n = 4). Central point thickness (CPT) and retinal thickness (RT) in 9 Early Treatment Diabetic Retinopathy Study (ETDRS) subfields, including central subfield (CSF), were analyzed. Statistical analyses were carried out using the analysis of variance. Results Overall, the mean CPT was 227.3 ± 23.2 μm, and mean CSF was 270.2 ± 22.5 μm. Among the ETDRS subfields, the outer nasal quadrant had the maximum thickness (mean ± standard deviation, 339.5 ± 16.9 μm). The RT did not show significant difference with age ( P = .62) or with gender ( P = .1). However, there was a suggestion of significant difference in RT of Black subjects as compared with White subjects ( P = .007) in the present study. Conclusions Normative values for macular thickness in otherwise healthy eyes were measured to be 227.3 μm (CPT) and 270.2 μm (CSF) using commercially available Spectralis SD-OCT. Based on the data, the present study proposes the guidelines for normal CSF thickness to be 315 μm for future studies using macular thickness measurements with Spectralis SD-OCT (Heidelberg Engineering, Vista, California, USA).
To establish normative data for the macular thickness by spectral-domain optical coherence tomography (SD-OCT) in subjects with no known retinal disease. Prospective, observational study in an academic institutional setting. Fifty subjects (age range, 20 to 84 years) with no known retinal disease, best-corrected visual acuity 20/20, and normal intraocular pressure were enrolled. The subjects were divided into 3 age groups: group 1 included subjects 20 to 40 years of age; group 2 included subjects 41 to 60 years of age; and group 3 included subjects 61 years of age and older. All subjects underwent a complete ophthalmologic examination to rule out any retinal diseases or glaucoma. All the OCT scans were performed by a single operator, and data obtained from the right eyes were analyzed by default, unless the right eye did not meet the inclusion criteria, and then data from left eyes were analyzed (n = 4). Central point thickness (CPT) and retinal thickness (RT) in 9 Early Treatment Diabetic Retinopathy Study (ETDRS) subfields, including central subfield (CSF), were analyzed. Statistical analyses were carried out using the analysis of variance. Overall, the mean CPT was 227.3 +/- 23.2 microm, and mean CSF was 270.2 +/- 22.5 microm. Among the ETDRS subfields, the outer nasal quadrant had the maximum thickness (mean +/- standard deviation, 339.5 +/- 16.9 microm). The RT did not show significant difference with age (P = .62) or with gender (P = .1). However, there was a suggestion of significant difference in RT of Black subjects as compared with White subjects (P = .007) in the present study. Normative values for macular thickness in otherwise healthy eyes were measured to be 227.3 microm (CPT) and 270.2 microm (CSF) using commercially available Spectralis SD-OCT. Based on the data, the present study proposes the guidelines for normal CSF thickness to be 315 microm for future studies using macular thickness measurements with Spectralis SD-OCT (Heidelberg Engineering, Vista, California, USA).
To establish normative data for the macular thickness by spectral-domain optical coherence tomography (SD-OCT) in subjects with no known retinal disease. Prospective, observational study in an academic institutional setting. Fifty subjects (age range, 20 to 84 years) with no known retinal disease, best-corrected visual acuity 20/20, and normal intraocular pressure were enrolled. The subjects were divided into 3 age groups: group 1 included subjects 20 to 40 years of age; group 2 included subjects 41 to 60 years of age; and group 3 included subjects 61 years of age and older. All subjects underwent a complete ophthalmologic examination to rule out any retinal diseases or glaucoma. All the OCT scans were performed by a single operator, and data obtained from the right eyes were analyzed by default, unless the right eye did not meet the inclusion criteria, and then data from left eyes were analyzed (n = 4). Central point thickness (CPT) and retinal thickness (RT) in 9 Early Treatment Diabetic Retinopathy Study (ETDRS) subfields, including central subfield (CSF), were analyzed. Statistical analyses were carried out using the analysis of variance. Overall, the mean CPT was 227.3 ± 23.2 μm, and mean CSF was 270.2 ± 22.5 μm. Among the ETDRS subfields, the outer nasal quadrant had the maximum thickness (mean ± standard deviation, 339.5 ± 16.9 μm). The RT did not show significant difference with age ( P = .62) or with gender ( P = .1). However, there was a suggestion of significant difference in RT of Black subjects as compared with White subjects ( P = .007) in the present study. Normative values for macular thickness in otherwise healthy eyes were measured to be 227.3 μm (CPT) and 270.2 μm (CSF) using commercially available Spectralis SD-OCT. Based on the data, the present study proposes the guidelines for normal CSF thickness to be 315 μm for future studies using macular thickness measurements with Spectralis SD-OCT (Heidelberg Engineering, Vista, California, USA).
Author Chalam, Kakarla V
Grover, Sandeep
Murthy, Ravi K
Brar, Vikram S
Author_xml – sequence: 1
  fullname: Grover, Sandeep
– sequence: 2
  fullname: Murthy, Ravi K
– sequence: 3
  fullname: Brar, Vikram S
– sequence: 4
  fullname: Chalam, Kakarla V
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21797660$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19427616$$D View this record in MEDLINE/PubMed
BookMark eNp9klFv0zAUhS00xLrBD-AFWUIgeEi5TmI70SQk1AJDGuxh5dmy3ZvVXRJ3djKp_x5HLUzaA0-Wpe9cH59zz8hJ73sk5DWDOQMmPm3neuvnOUA9h2IOIJ6RGatknbGqZidkBgB5Vhd1eUrOYtymq5ClfEFOWV3mUjAxI_e_fOj04B6QLvWgaeMD_ant2OpAVxtn73qMkZo9vXS3m2yJjevd4HxPb3Zoh6DbbOk77Xp6vRuc1S1d-A0G7C3Sle_8bdC7zZ5--Eu7-PEled7oNuKr43lOfn_7ulpcZlfX338svlxllhcwZAIY58YIwddVLRGb2lQVa0qL1hbS5AaNaKrSmqpsOGMlIEcsDaxN3kgBpjgn7w9zd8HfjxgH1blosW11j36MSkgOnOeQwLdPwK0fQ5-8KSZKDlBKJhPFDpQNPsaAjdoF1-mwVwzU1IbaqtSGmtpQUKiUddK8OU4eTYfrR8Ux_gS8OwI6pvCaoHvr4j8uZ7KWQkwWLw4cpsAeHAYVrZtCXruQglVr7_5r4_MTtW1TjenBO9xjfPytirkCdTOtzbQ1UEMayHjxB0Byvjw
CODEN AJOPAA
CitedBy_id crossref_primary_10_3233_JAD_231414
crossref_primary_10_1167_iovs_63_12_4
crossref_primary_10_1007_s10384_016_0486_5
crossref_primary_10_1016_j_oret_2020_09_023
crossref_primary_10_1097_IAE_0000000000002378
crossref_primary_10_5301_ejo_5000845
crossref_primary_10_4103_IJO_IJO_146_23
crossref_primary_10_1016_j_arr_2016_05_013
crossref_primary_10_1002_brb3_2592
crossref_primary_10_3928_15428877_20111222_02
crossref_primary_10_1186_s12886_016_0232_2
crossref_primary_10_1097_MD_0000000000005441
crossref_primary_10_1007_s13410_015_0362_8
crossref_primary_10_1371_journal_pone_0067265
crossref_primary_10_1007_s00417_014_2672_9
crossref_primary_10_1097_IAE_0b013e31820d3f13
crossref_primary_10_1007_s00417_018_4004_y
crossref_primary_10_1538_expanim_22_0022
crossref_primary_10_1016_j_ajo_2010_06_034
crossref_primary_10_1167_iovs_64_13_24
crossref_primary_10_1016_j_ophtha_2012_05_018
crossref_primary_10_1016_j_ajo_2013_04_027
crossref_primary_10_1136_bmjopen_2017_016142
crossref_primary_10_1016_j_ajo_2013_04_026
crossref_primary_10_1016_j_survophthal_2017_05_006
crossref_primary_10_1016_j_ajo_2016_10_013
crossref_primary_10_1371_journal_pone_0037638
crossref_primary_10_3109_09273948_2013_871566
crossref_primary_10_1371_journal_pone_0216351
crossref_primary_10_1186_s12886_015_0019_x
crossref_primary_10_3390_e23060699
crossref_primary_10_1016_j_oftal_2019_07_010
crossref_primary_10_1016_j_jfo_2018_09_005
crossref_primary_10_1097_IAE_0b013e3181cd4803
crossref_primary_10_1155_2019_1698967
crossref_primary_10_5301_ejo_5000869
crossref_primary_10_1007_s00417_022_05664_z
crossref_primary_10_5005_jp_journals_10008_1165
crossref_primary_10_1016_j_ajo_2012_06_028
crossref_primary_10_1007_s00417_017_3681_2
crossref_primary_10_1177_1120672119880394
crossref_primary_10_1016_j_ophtha_2016_08_025
crossref_primary_10_18231_j_ijceo_2021_048
crossref_primary_10_1167_iovs_65_2_26
crossref_primary_10_4102_aveh_v74i1_300
crossref_primary_10_1007_s10384_011_0085_4
crossref_primary_10_3109_15569527_2014_950380
crossref_primary_10_1097_IAE_0000000000002696
crossref_primary_10_1097_APO_0000000000000153
crossref_primary_10_2147_OPTH_S257462
crossref_primary_10_3390_ijms241813932
crossref_primary_10_1007_s00417_018_3951_7
crossref_primary_10_4102_aveh_v78i1_482
crossref_primary_10_1007_s00417_021_05203_2
crossref_primary_10_1016_j_ajo_2012_11_029
crossref_primary_10_1016_j_exer_2017_09_001
crossref_primary_10_1007_s00417_012_2044_2
crossref_primary_10_1007_s00417_017_3617_x
crossref_primary_10_1038_s41598_020_73645_5
crossref_primary_10_1016_j_ajo_2024_06_016
crossref_primary_10_1186_s40942_019_0178_7
crossref_primary_10_1167_tvst_9_5_24
crossref_primary_10_1186_s12886_018_0862_7
crossref_primary_10_21516_2072_0076_2020_13_2_99_104
crossref_primary_10_1038_s41598_020_79424_6
crossref_primary_10_1111_j_1755_3768_2012_02398_x
crossref_primary_10_1136_bjophthalmol_2021_319587
crossref_primary_10_3928_23258160_20170329_01
crossref_primary_10_1007_s00417_018_3901_4
crossref_primary_10_1177_24741264231165611
crossref_primary_10_1016_j_ajo_2010_12_010
crossref_primary_10_1016_j_ophtha_2023_05_023
crossref_primary_10_1016_j_preteyeres_2017_04_003
crossref_primary_10_1097_IAE_0000000000001136
crossref_primary_10_1038_eye_2016_214
crossref_primary_10_1007_s00417_017_3749_z
crossref_primary_10_1097_IAE_0000000000000847
crossref_primary_10_1007_s00417_021_05191_3
crossref_primary_10_1177_11206721231183471
crossref_primary_10_3390_jcm9103317
crossref_primary_10_5301_ejo_5000949
crossref_primary_10_1155_2018_1078531
crossref_primary_10_3928_15428877_20120424_01
crossref_primary_10_1007_s00417_016_3559_8
crossref_primary_10_1186_s40662_018_0119_9
crossref_primary_10_1016_j_ajo_2011_08_024
crossref_primary_10_1136_bmjopen_2016_012972
crossref_primary_10_6000_2292_2598_2020_08_02_20
crossref_primary_10_1111_opo_12321
crossref_primary_10_1097_OPX_0b013e3182186a36
crossref_primary_10_18632_oncotarget_10442
crossref_primary_10_1159_000450958
crossref_primary_10_1016_j_ophtha_2019_03_029
crossref_primary_10_1186_s12348_022_00314_1
crossref_primary_10_1364_BOE_7_000629
crossref_primary_10_1007_s10384_016_0460_2
crossref_primary_10_1186_s12886_020_01391_3
crossref_primary_10_1038_s42256_020_00247_1
crossref_primary_10_1016_j_nmd_2019_11_012
crossref_primary_10_1016_j_ophtha_2016_03_010
crossref_primary_10_18008_1816_5095_2022_4_705_718
crossref_primary_10_1111_j_1442_9071_2011_02593_x
crossref_primary_10_1371_journal_pone_0276958
crossref_primary_10_1089_jop_2013_0010
crossref_primary_10_1177_1120672119899379
crossref_primary_10_1038_eye_2016_118
crossref_primary_10_1038_eye_2016_238
crossref_primary_10_4102_aveh_v76i1_374
crossref_primary_10_1016_j_ajo_2009_08_037
crossref_primary_10_1002_humu_22822
crossref_primary_10_1136_bjophthalmol_2013_304564
crossref_primary_10_1016_j_bj_2016_04_003
crossref_primary_10_1016_j_exer_2018_01_012
crossref_primary_10_1167_tvst_10_2_10
crossref_primary_10_3109_02713683_2014_952828
crossref_primary_10_1080_02713683_2021_1908566
crossref_primary_10_1007_s00417_010_1453_3
crossref_primary_10_1007_s00417_023_06086_1
crossref_primary_10_1016_j_exer_2019_107856
crossref_primary_10_1186_s40942_023_00459_8
crossref_primary_10_3389_fmed_2023_1275308
crossref_primary_10_1371_journal_pone_0253720
crossref_primary_10_5301_ejo_5000582
crossref_primary_10_1097_IAE_0000000000000239
crossref_primary_10_1016_j_ogla_2023_09_003
crossref_primary_10_1080_09273948_2022_2113806
crossref_primary_10_1186_s12886_018_0842_y
crossref_primary_10_1007_s00417_019_04451_7
crossref_primary_10_1109_ACCESS_2020_2977355
crossref_primary_10_1136_bjo_2022_321766
crossref_primary_10_1016_j_ophtha_2009_12_014
crossref_primary_10_1007_s10633_013_9375_0
crossref_primary_10_1016_j_sjopt_2014_10_003
crossref_primary_10_1167_iovs_64_15_11
crossref_primary_10_3390_diagnostics13081377
crossref_primary_10_12659_MSM_893221
crossref_primary_10_1016_j_ajo_2010_07_026
crossref_primary_10_1016_j_oftale_2013_01_003
crossref_primary_10_1038_s41598_020_78059_x
crossref_primary_10_1016_j_ajo_2014_08_039
crossref_primary_10_1016_j_survophthal_2020_03_002
crossref_primary_10_1371_journal_pone_0203324
crossref_primary_10_5301_ejo_5000904
crossref_primary_10_1007_s00417_016_3512_x
crossref_primary_10_1016_j_ajo_2017_01_020
crossref_primary_10_3109_02713683_2015_1119854
crossref_primary_10_1371_journal_pone_0147782
crossref_primary_10_1186_1471_2415_10_13
crossref_primary_10_1136_bjophthalmol_2018_312349
crossref_primary_10_1097_j_jcrs_0000000000000226
crossref_primary_10_1080_09286586_2023_2251153
crossref_primary_10_1016_j_oftale_2019_07_006
crossref_primary_10_1016_j_pdpdt_2022_103131
crossref_primary_10_1371_journal_pone_0180450
crossref_primary_10_2147_OPTH_S272431
crossref_primary_10_36299_jkgs_2022_11_1_21
crossref_primary_10_5301_ejo_5000898
crossref_primary_10_1016_j_oftal_2013_01_005
crossref_primary_10_1016_j_ajo_2022_09_002
crossref_primary_10_1016_j_ajo_2011_01_027
crossref_primary_10_3389_fopht_2024_1372429
crossref_primary_10_1007_s00296_016_3593_1
crossref_primary_10_1016_j_parkreldis_2012_07_012
crossref_primary_10_1089_jop_2013_0214
crossref_primary_10_3390_jcm12123976
crossref_primary_10_1155_2015_715798
crossref_primary_10_1371_journal_pone_0111203
crossref_primary_10_1007_s00417_011_1708_7
crossref_primary_10_1007_s00417_018_4126_2
crossref_primary_10_1016_j_xops_2023_100386
crossref_primary_10_1097_IAE_0000000000003032
crossref_primary_10_1016_j_ajo_2014_01_020
crossref_primary_10_3928_15428877_20100430_02
crossref_primary_10_3892_etm_2017_4820
crossref_primary_10_3389_fneur_2019_01117
crossref_primary_10_1007_s00417_015_3075_2
crossref_primary_10_4103_2347_5617_164633
crossref_primary_10_1007_s10384_012_0192_x
crossref_primary_10_1007_s00417_012_2173_7
crossref_primary_10_3928_23258160_20180221_01
crossref_primary_10_1016_j_ophtha_2012_07_048
crossref_primary_10_1167_iovs_18_25332
crossref_primary_10_31362_patd_428103
crossref_primary_10_3928_23258160_20121221_06
crossref_primary_10_4102_aveh_v75i1_330
crossref_primary_10_1016_j_exer_2016_05_013
crossref_primary_10_1186_s40942_020_00270_9
crossref_primary_10_1097_IJG_0b013e3182070cc6
crossref_primary_10_1371_journal_pone_0169520
crossref_primary_10_1016_j_ajo_2017_02_025
crossref_primary_10_12771_emj_2017_40_2_71
crossref_primary_10_3390_jcm10122659
crossref_primary_10_1080_13816810_2017_1401088
crossref_primary_10_1097_OPX_0b013e318251293a
crossref_primary_10_1155_2014_865394
crossref_primary_10_1038_eye_2011_293
crossref_primary_10_1016_j_oret_2017_12_012
crossref_primary_10_1038_s41598_019_49816_4
crossref_primary_10_1016_j_ajo_2016_05_015
crossref_primary_10_1097_IAE_0000000000000464
crossref_primary_10_1007_s00417_017_3669_y
crossref_primary_10_17925_USOR_2018_11_2_91
crossref_primary_10_1155_2013_434560
crossref_primary_10_3928_23258160_20170630_01
crossref_primary_10_1007_s00417_011_1630_z
crossref_primary_10_1007_s10633_012_9367_5
Cites_doi 10.1016/j.ophtha.2005.05.023
10.1016/S0161-6420(95)31032-9
10.1016/S0161-6420(13)38009-9
10.1097/00006982-200102000-00010
10.1016/j.ophtha.2007.04.052
10.1001/archopht.124.2.193
10.1177/112067210201200205
10.1126/science.1957169
10.1167/iovs.08-2113
10.1016/j.ophtha.2007.02.006
10.1016/j.ophtha.2006.05.046
10.1167/iovs.07-1000
10.1016/j.ophtha.2006.03.020
10.1167/iovs.08-1967
10.1001/archopht.1995.01100080071031
10.3928/1542-8877-20000501-04
ContentType Journal Article
Copyright Elsevier Inc.
2009 Elsevier Inc.
2009 INIST-CNRS
Copyright Elsevier Limited Aug 2009
Copyright_xml – notice: Elsevier Inc.
– notice: 2009 Elsevier Inc.
– notice: 2009 INIST-CNRS
– notice: Copyright Elsevier Limited Aug 2009
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
K9.
NAPCQ
7X8
DOI 10.1016/j.ajo.2009.03.006
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE

ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1879-1891
EndPage 271
ExternalDocumentID 3556496781
10_1016_j_ajo_2009_03_006
19427616
21797660
S0002939409001615
1_s2_0_S0002939409001615
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations California
GeographicLocations_xml – name: California
GroupedDBID ---
--K
--M
-~X
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1CY
1P~
1~.
1~5
23M
3V.
4.4
457
4G.
53G
5GY
5RE
5VS
6J9
7-5
71M
7RV
7X7
8FI
8P~
AABNK
AACTN
AAEDT
AAEDW
AAHTB
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQQT
AAQXK
AAWTL
AAXKI
AAXUO
ABBQC
ABCQX
ABFNM
ABFRF
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABPEJ
ABXDB
ACDAQ
ACGFO
ACGFS
ACIUM
ACNCT
ACRLP
ADBBV
ADEZE
ADFRT
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AEVXI
AFCTW
AFFNX
AFJKZ
AFKRA
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHMBA
AI.
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
AZQEC
BENPR
BKEYQ
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
CS3
EBS
EFJIC
EJD
EMOBN
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
FYUFA
G-Q
G8K
GBLVA
GUQSH
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
M1P
M2O
M41
MO0
N4W
N9A
O-L
O9-
OAUVE
OF-
OPF
OQ~
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
R2-
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SEL
SES
SPCBC
SSH
SSZ
SV3
T5K
UNMZH
UV1
VH1
WH7
WOW
X7M
XPP
Z5R
ZGI
ZXP
~G-
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
EFLBG
LCYCR
ZA5
08R
AAPBV
AAUGY
ABPIF
ABPTK
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
ABDPE
CITATION
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c530t-60155bb665d897eef9b881f4cecc37b2beb6f84cb84f51140e5ee4b0db2f760b3
ISSN 0002-9394
IngestDate Fri Oct 25 02:04:25 EDT 2024
Thu Oct 10 21:48:05 EDT 2024
Thu Nov 21 23:13:40 EST 2024
Sat Sep 28 07:46:13 EDT 2024
Sun Oct 22 16:05:39 EDT 2023
Fri Feb 23 02:24:30 EST 2024
Tue Oct 15 14:37:43 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Thickness
High
Definition
Macula
Ophthalmology
Optical coherence tomography
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c530t-60155bb665d897eef9b881f4cecc37b2beb6f84cb84f51140e5ee4b0db2f760b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 19427616
PQID 1645004717
PQPubID 41749
PageCount 6
ParticipantIDs proquest_miscellaneous_67505520
proquest_journals_1645004717
crossref_primary_10_1016_j_ajo_2009_03_006
pubmed_primary_19427616
pascalfrancis_primary_21797660
elsevier_sciencedirect_doi_10_1016_j_ajo_2009_03_006
elsevier_clinicalkeyesjournals_1_s2_0_S0002939409001615
PublicationCentury 2000
PublicationDate 2009-08-01
PublicationDateYYYYMMDD 2009-08-01
PublicationDate_xml – month: 08
  year: 2009
  text: 2009-08-01
  day: 01
PublicationDecade 2000
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
– name: Chicago
PublicationTitle American journal of ophthalmology
PublicationTitleAlternate Am J Ophthalmol
PublicationYear 2009
Publisher Elsevier Inc
Elsevier
Elsevier Limited
Publisher_xml – name: Elsevier Inc
– name: Elsevier
– name: Elsevier Limited
References Konno, Akiba, Yoshida (bib10) 2001; 21
Alam, Zawadzki, Choi (bib7) 2006; 113
Chan, Duker, Ko (bib9) 2006; 124
Forooghian, Cukras, Meyerle (bib15) 2008; 49
Hee, Puliafito, Wong (bib3) 1995; 113
Schaudig, Glaefke, Scholz, Richard (bib4) 2000; 31
Puliafito, Hee, Lin (bib2) 1995; 102
Lam, Chan, Mohamed (bib13) 2007; 114
Kelty, Payne, Trivedi (bib18) 2008; 49
Chew, Strauber, Beck (bib14) 2007; 114
Sanchez-Tocino, Alvarez-Vidal, Maldonado (bib5) 2002; 43
Wojtkowski, Srinivasan, Fujimoto (bib6) 2005; 112
Srinivasan, Wojtkowski, Witkin (bib8) 2006; 113
Yamaike, Tsjikawa, Ota (bib16) 2008; 115
Massin, Erginay, Haouchine (bib11) 2002; 12
Fleckenstein, Charbel Issa, Martin Helb (bib17) 2008; 49
(bib12) 1991; 98
Huang, Swanson, Lin (bib1) 1991; 254
Chauhan, Marshall (bib19) 1999; 40
Chan (10.1016/j.ajo.2009.03.006_bib9) 2006; 124
Huang (10.1016/j.ajo.2009.03.006_bib1) 1991; 254
Alam (10.1016/j.ajo.2009.03.006_bib7) 2006; 113
Fleckenstein (10.1016/j.ajo.2009.03.006_bib17) 2008; 49
Hee (10.1016/j.ajo.2009.03.006_bib3) 1995; 113
Chew (10.1016/j.ajo.2009.03.006_bib14) 2007; 114
Puliafito (10.1016/j.ajo.2009.03.006_bib2) 1995; 102
Wojtkowski (10.1016/j.ajo.2009.03.006_bib6) 2005; 112
Chauhan (10.1016/j.ajo.2009.03.006_bib19) 1999; 40
Yamaike (10.1016/j.ajo.2009.03.006_bib16) 2008; 115
Kelty (10.1016/j.ajo.2009.03.006_bib18) 2008; 49
Schaudig (10.1016/j.ajo.2009.03.006_bib4) 2000; 31
Konno (10.1016/j.ajo.2009.03.006_bib10) 2001; 21
Massin (10.1016/j.ajo.2009.03.006_bib11) 2002; 12
(10.1016/j.ajo.2009.03.006_bib12) 1991; 98
Forooghian (10.1016/j.ajo.2009.03.006_bib15) 2008; 49
Sanchez-Tocino (10.1016/j.ajo.2009.03.006_bib5) 2002; 43
Srinivasan (10.1016/j.ajo.2009.03.006_bib8) 2006; 113
Lam (10.1016/j.ajo.2009.03.006_bib13) 2007; 114
References_xml – volume: 43
  start-page: 1588
  year: 2002
  end-page: 1594
  ident: bib5
  article-title: Retinal thickness study with optical coherence tomography in patients with diabetes
  publication-title: Invest Ophthalmol Vis Sci
  contributor:
    fullname: Maldonado
– volume: 112
  start-page: 1734
  year: 2005
  end-page: 1746
  ident: bib6
  article-title: Three-dimensional retinal imaging with high-speed ultra-high resolution optical coherence tomography
  publication-title: Ophthalmology
  contributor:
    fullname: Fujimoto
– volume: 254
  start-page: 1178
  year: 1991
  end-page: 1181
  ident: bib1
  article-title: Optical coherence tomography
  publication-title: Science
  contributor:
    fullname: Lin
– volume: 102
  start-page: 217
  year: 1995
  end-page: 229
  ident: bib2
  article-title: Imaging of macular diseases with optical coherence tomography
  publication-title: Ophthalmology
  contributor:
    fullname: Lin
– volume: 21
  start-page: 57
  year: 2001
  end-page: 61
  ident: bib10
  article-title: Retinal thickness measurements with optical coherence tomography and the retinal thickness analyzer
  publication-title: Retina
  contributor:
    fullname: Yoshida
– volume: 98
  start-page: 741
  year: 1991
  end-page: 756
  ident: bib12
  article-title: ETDRS Report No. 7: Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics
  publication-title: Ophthalmology
– volume: 115
  start-page: 355
  year: 2008
  end-page: 362
  ident: bib16
  article-title: Three-dimensional imaging of cystoid macular edema in retinal vein occlusion
  publication-title: Ophthalmology
  contributor:
    fullname: Ota
– volume: 113
  start-page: 1425
  year: 2006
  end-page: 1431
  ident: bib7
  article-title: Clinical application of rapid serial Fourier-domain optical coherence tomography for macular imaging
  publication-title: Ophthalmology
  contributor:
    fullname: Choi
– volume: 113
  start-page: 1019
  year: 1995
  end-page: 1029
  ident: bib3
  article-title: Quantitative assessment of macular edema with optical coherence tomography
  publication-title: Arch Ophthalmol
  contributor:
    fullname: Wong
– volume: 114
  start-page: 2162
  year: 2007
  end-page: 2167
  ident: bib13
  article-title: Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema
  publication-title: Ophthalmology
  contributor:
    fullname: Mohamed
– volume: 40
  start-page: 2332
  year: 1999
  end-page: 2342
  ident: bib19
  article-title: The interpretation of optical coherence tomography images of the retina
  publication-title: Invest Ophthalmol Vis Sci
  contributor:
    fullname: Marshall
– volume: 113
  start-page: 2054
  year: 2006
  end-page: 2065
  ident: bib8
  article-title: High-definition and 3-dimensional imaging of macular pathologies with high-speed ultra-high resolution optical coherence tomography
  publication-title: Ophthalmology
  contributor:
    fullname: Witkin
– volume: 49
  start-page: 2668
  year: 2008
  end-page: 2672
  ident: bib18
  article-title: Macular thickness assessment in healthy eyes based on ethnicity using Stratus optical coherence tomography
  publication-title: Invest Ophthalmol Vis Sci
  contributor:
    fullname: Trivedi
– volume: 124
  start-page: 193
  year: 2006
  end-page: 198
  ident: bib9
  article-title: Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography
  publication-title: Arch Ophthalmol
  contributor:
    fullname: Ko
– volume: 114
  start-page: 1190
  year: 2007
  end-page: 1196
  ident: bib14
  article-title: Diabetic Retinopathy Clinical Research Network
  publication-title: Ophthalmology
  contributor:
    fullname: Beck
– volume: 49
  start-page: 4137
  year: 2008
  end-page: 4144
  ident: bib17
  article-title: High resolution spectral-domain OCT imaging in geographic atrophy associated with age-related macular degeneration
  publication-title: Invest Ophthalmol Vis Sci
  contributor:
    fullname: Martin Helb
– volume: 49
  start-page: 4290
  year: 2008
  end-page: 4296
  ident: bib15
  article-title: Evaluation of time domain and spectral-domain optical coherence tomography in the measurement of diabetic macular edema
  publication-title: Invest Ophthalmol Vis Sci
  contributor:
    fullname: Meyerle
– volume: 31
  start-page: 182
  year: 2000
  end-page: 186
  ident: bib4
  article-title: Optical coherence tomography for retinal thickness measurement in diabetic patients without clinically significant macular edema
  publication-title: Ophthalmic Surg Lasers
  contributor:
    fullname: Richard
– volume: 12
  start-page: 102
  year: 2002
  end-page: 108
  ident: bib11
  article-title: Retinal thickness in healthy and diabetic subjects measured using optical coherence tomography mapping software
  publication-title: Eur J Ophthalmol
  contributor:
    fullname: Haouchine
– volume: 112
  start-page: 1734
  year: 2005
  ident: 10.1016/j.ajo.2009.03.006_bib6
  article-title: Three-dimensional retinal imaging with high-speed ultra-high resolution optical coherence tomography
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2005.05.023
  contributor:
    fullname: Wojtkowski
– volume: 102
  start-page: 217
  year: 1995
  ident: 10.1016/j.ajo.2009.03.006_bib2
  article-title: Imaging of macular diseases with optical coherence tomography
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(95)31032-9
  contributor:
    fullname: Puliafito
– volume: 98
  start-page: 741
  year: 1991
  ident: 10.1016/j.ajo.2009.03.006_bib12
  article-title: ETDRS Report No. 7: Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(13)38009-9
– volume: 21
  start-page: 57
  year: 2001
  ident: 10.1016/j.ajo.2009.03.006_bib10
  article-title: Retinal thickness measurements with optical coherence tomography and the retinal thickness analyzer
  publication-title: Retina
  doi: 10.1097/00006982-200102000-00010
  contributor:
    fullname: Konno
– volume: 115
  start-page: 355
  year: 2008
  ident: 10.1016/j.ajo.2009.03.006_bib16
  article-title: Three-dimensional imaging of cystoid macular edema in retinal vein occlusion
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2007.04.052
  contributor:
    fullname: Yamaike
– volume: 124
  start-page: 193
  year: 2006
  ident: 10.1016/j.ajo.2009.03.006_bib9
  article-title: Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.124.2.193
  contributor:
    fullname: Chan
– volume: 12
  start-page: 102
  year: 2002
  ident: 10.1016/j.ajo.2009.03.006_bib11
  article-title: Retinal thickness in healthy and diabetic subjects measured using optical coherence tomography mapping software
  publication-title: Eur J Ophthalmol
  doi: 10.1177/112067210201200205
  contributor:
    fullname: Massin
– volume: 254
  start-page: 1178
  year: 1991
  ident: 10.1016/j.ajo.2009.03.006_bib1
  article-title: Optical coherence tomography
  publication-title: Science
  doi: 10.1126/science.1957169
  contributor:
    fullname: Huang
– volume: 40
  start-page: 2332
  year: 1999
  ident: 10.1016/j.ajo.2009.03.006_bib19
  article-title: The interpretation of optical coherence tomography images of the retina
  publication-title: Invest Ophthalmol Vis Sci
  contributor:
    fullname: Chauhan
– volume: 49
  start-page: 4290
  year: 2008
  ident: 10.1016/j.ajo.2009.03.006_bib15
  article-title: Evaluation of time domain and spectral-domain optical coherence tomography in the measurement of diabetic macular edema
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.08-2113
  contributor:
    fullname: Forooghian
– volume: 43
  start-page: 1588
  year: 2002
  ident: 10.1016/j.ajo.2009.03.006_bib5
  article-title: Retinal thickness study with optical coherence tomography in patients with diabetes
  publication-title: Invest Ophthalmol Vis Sci
  contributor:
    fullname: Sanchez-Tocino
– volume: 114
  start-page: 2162
  year: 2007
  ident: 10.1016/j.ajo.2009.03.006_bib13
  article-title: Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2007.02.006
  contributor:
    fullname: Lam
– volume: 113
  start-page: 2054
  year: 2006
  ident: 10.1016/j.ajo.2009.03.006_bib8
  article-title: High-definition and 3-dimensional imaging of macular pathologies with high-speed ultra-high resolution optical coherence tomography
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2006.05.046
  contributor:
    fullname: Srinivasan
– volume: 49
  start-page: 2668
  year: 2008
  ident: 10.1016/j.ajo.2009.03.006_bib18
  article-title: Macular thickness assessment in healthy eyes based on ethnicity using Stratus optical coherence tomography
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.07-1000
  contributor:
    fullname: Kelty
– volume: 113
  start-page: 1425
  year: 2006
  ident: 10.1016/j.ajo.2009.03.006_bib7
  article-title: Clinical application of rapid serial Fourier-domain optical coherence tomography for macular imaging
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2006.03.020
  contributor:
    fullname: Alam
– volume: 49
  start-page: 4137
  year: 2008
  ident: 10.1016/j.ajo.2009.03.006_bib17
  article-title: High resolution spectral-domain OCT imaging in geographic atrophy associated with age-related macular degeneration
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.08-1967
  contributor:
    fullname: Fleckenstein
– volume: 113
  start-page: 1019
  year: 1995
  ident: 10.1016/j.ajo.2009.03.006_bib3
  article-title: Quantitative assessment of macular edema with optical coherence tomography
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1995.01100080071031
  contributor:
    fullname: Hee
– volume: 114
  start-page: 1190
  year: 2007
  ident: 10.1016/j.ajo.2009.03.006_bib14
  article-title: Diabetic Retinopathy Clinical Research Network
  publication-title: Ophthalmology
  contributor:
    fullname: Chew
– volume: 31
  start-page: 182
  year: 2000
  ident: 10.1016/j.ajo.2009.03.006_bib4
  article-title: Optical coherence tomography for retinal thickness measurement in diabetic patients without clinically significant macular edema
  publication-title: Ophthalmic Surg Lasers
  doi: 10.3928/1542-8877-20000501-04
  contributor:
    fullname: Schaudig
SSID ssj0006747
Score 2.4819977
Snippet Purpose To establish normative data for the macular thickness by spectral-domain optical coherence tomography (SD-OCT) in subjects with no known retinal...
To establish normative data for the macular thickness by spectral-domain optical coherence tomography (SD-OCT) in subjects with no known retinal disease....
PURPOSETo establish normative data for the macular thickness by spectral-domain optical coherence tomography (SD-OCT) in subjects with no known retinal...
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 266
SubjectTerms Adult
Age
Aged
Aged, 80 and over
Aging - physiology
Biological and medical sciences
Body Weights and Measures
Diabetes
Diabetic retinopathy
Female
Fourier Analysis
Humans
Intraocular Pressure - physiology
Macula Lutea - anatomy & histology
Male
Medical sciences
Middle Aged
Miscellaneous
Ophthalmology
Prospective Studies
Reference Values
Standard deviation
Tomography, Optical Coherence - methods
Visual Acuity - physiology
Young Adult
Title Normative Data for Macular Thickness by High-Definition Spectral-Domain Optical Coherence Tomography (Spectralis)
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0002939409001615
https://dx.doi.org/10.1016/j.ajo.2009.03.006
https://www.ncbi.nlm.nih.gov/pubmed/19427616
https://www.proquest.com/docview/1645004717
https://search.proquest.com/docview/67505520
Volume 148
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELe6ISEkhPimMIYfeACqVInj2MkjWguTpg2JlgnxYtmJo6Zd09IPJP57znG-2mkIkHhJK8d13Px-vjvb5zuEXitfppz7xEm8VDnUS2JH-QCIlMSLiadJEJuzw6cjfvE1HAzpsNOp8rg2Zf8VaSgDrM3J2b9Au24UCuA7YA5XQB2uf4T7hTVCjT-Q3MjCi_BcWmfT8SSLZ4VoA5vTOHg4A51meWaFhjlyuZJXzmAxl1ne-7S0q9zm_IaNRDtezMv41sYsreqbGAVR28St94BaQSkWy8lmIq_mO2v4H1eV--jIrGTrZQv8TQm-_JH1zvqtjf-i_mU2W8l5b1TfOIHGLbPP5Mw48PYu-zvrGVHtTVcuslUHbXb8QAvBHfk2H3JfW1kd8sjxQpvsqxbmNGyxlrRFM2MtLU9s4pdrCsSuZUz7croog5maCLh7wboL9T8yfTJdciNrNx-gWwSknRG234LPtTnAOOXVHMxUr7bWCyfDvcfcZBzdXco1QJ7aXCs3T4YKo2h8H90rZzP4vaXhA9TR-UN0-7z013iEvtdsxIaNGNiISzbimo1Y_cR7bMR7bMQlG3HNRtywEb9puPj2MfryYTg-OXXKJB9OHPjuxmHGaFeKsSAJI651Gqkw9FIag2zxuSJKK5aGNFYhTWFyQF0daE2VmyiScuYq_wk6zBe5foYwTeIQJvzUk_BBZSyDNPQl01Ap0Vx7XfSuertiaWO5iMrJcSoACpOTNRKuLwCKLuLV-xfVIWVQq3pdDp618MSaCFdc40EX0fqXpRlrzVMBJPvdA493UK67SEBncsbcLjqqYBdNJxgNTMRXj3fRq_o2qAiz7ydzvdiuBYNZQRAQaOCpJUvz7yNKOPPY83_r8gt0pxnBR-hws9rql-hgnWyPizHwC_lc6AM
link.rule.ids 315,782,786,27933,27934
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Normative+Data+for+Macular+Thickness+by+High-Definition+Spectral-Domain+Optical+Coherence+Tomography+%28Spectralis%29&rft.jtitle=American+journal+of+ophthalmology&rft.au=Grover%2C+Sandeep&rft.au=Murthy%2C+Ravi+K.&rft.au=Brar%2C+Vikram+S.&rft.au=Chalam%2C+Kakarla+V.&rft.date=2009-08-01&rft.pub=Elsevier+Inc&rft.issn=0002-9394&rft.eissn=1879-1891&rft.volume=148&rft.issue=2&rft.spage=266&rft.epage=271&rft_id=info:doi/10.1016%2Fj.ajo.2009.03.006&rft.externalDocID=S0002939409001615
thumbnail_m http://sdu.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00029394%2FS0002939409X00073%2Fcov150h.gif